Price10-week line30-week trend line252 trading days
Relative strength vs the F&O universe RS line· baseline 100
The RS line is rising — the stock is out-performing the F&O universe, even if it isn’t at a fresh relative-strength high yet.
Returns
3M
+6.1%
6M
-7.3%
9M
+4.7%
12M
-19.7%
52-week range
₹3158₹4349
-20.1% from its 52-week high
Trend-health checklist0/5
✕Price above the 30-week line
✕30-week line is rising
✕10-week line above the 30-week line
✕Price above the 10-week line
✕Strength rank 70 or higher
Extension & risk
Above 30-week line
-3.1%
Below the line
30-week line (floor)
₹3586
structural floor
Risk back to floor
3.2%
if it returns there
10-week line
₹3500
nearer support
If price slid back to its 30-week line from here, that is 3.2% — the structural risk this far above the line. These are levels read from the price series, not a buy or sell call.
Futures positioning
Short buildupcurrent-month future · 27 days to expiry
Short buildup: futures price down and open interest up — fresh short positions being opened. The textbook bearish-leaning futures read.
Basis (future vs cash)
-0.69%
discount · ₹23.9
Open interest
+0.9%
vs prior session
Future price
₹3451
cash ₹3475
Futures move
-1.3%
today
Read from the current-month futures contract. Around monthly expiry these reads turn noisy as positions roll to the next series. Descriptive of positioning, not a buy or sell call.
Options positioning
current-month option chain · 26 strikes near the money · 27 days to expiry
ATM implied volatility
28.5%
call 29% · put 29%
Expected move to expiry
±7.8%
~ ±₹269 (1SD)
Put/call ratio (OI)
0.65
by volume 0.21
Max pain
₹3500
ATM ₹3450
Read from the current-month option strikes around the money. Implied volatility is solved from the at-the-money call and put; the expected move is the one-standard-deviation range those prices imply to expiry. Near expiry these compress as time value decays. Descriptive of option pricing, not a buy or sell call.
The 30-week line is computed live from adjusted prices; the checklist is computed from that same series, so chart and score always agree. Educational analysis only — not a recommendation, and not investment advice.